The pharmaceutical landscape for glucose is evolving, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this method offers a more convenient way to provide GLP-1 https://stevecxed382955.qowap.com/100014565/glp-1-patches-a-novel-approach-to-diabetes-control